Compounds > stavudine
Page last updated: 2024-08-22

stavudine and HIV-Associated Lipodystrophy Syndrome

stavudine has been researched along with HIV-Associated Lipodystrophy Syndrome in 75 studies

Research

Studies (75)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's56 (74.67)29.6817
2010's18 (24.00)24.3611
2020's1 (1.33)2.80

Authors

AuthorsStudies
Begovac, J; Šoštarić Zadro, A; Višković, K1
Fekade, D; Feleke, Y; Mezegebu, Y1
Chantratita, W; Chittamma, A; Kiertiburanakul, S; Kroll, MH; Pocathikorn, A; Puangpetch, A; Santon, S; Srisawasdi, P; Sukasem, C; Suwalak, T; Vanavanan, S1
Cournil, A; Diouf, A1
Bhutia, E; Hemal, A; Ramesh, KL; Yadav, TP1
Guo, F; Li, T; Lin, Q; Shao, H; Sun, P; Tian, J; Xu, Y; Yu, W; Zhou, X1
Boyko, EJ; Bryson, CL; Ioannou, GN; Weiss, NS1
Atté, EF; Rasschaert, F; Reid, T; van Griensven, J; Zachariah, R1
Begovac, J; Hernandez, A; Klasnic, K; Krolo, I; Richman, I; Romih, V; Rutherford, GW; Viskovic, K1
Blanche, S; Bonnet, F; Dollfus, C; Funck-Brentano, I; Levan, P; Trocme, N1
Portilla, J1
Berzins, B; Evans, S; Forand, J; Hafner, R; Murphy, R; Owens, S; Shevitz, A; Tashima, K; Tebas, P; Yarasheski, K; Zhang, J1
Belsey, E; Berzins, B; Chen, D; Choi, J; da Silva, B; Gerschenson, M; Kim, C; Libutti, DE; McComsey, GA; Murphy, RL; Shore, J; Taiwo, B; Weinstein, J1
Benn, P; Cartledge, J; Edwards, SG; Linney, A; Moyle, G; Reilly, G; Ruff, C; Sabin, CA; Sauret-Jackson, V1
Eriksson, P; Setzer, B; Sevastianova, K; Sievers, M; Sutinen, J; Wågsäter, D; Walker, UA; Yki-Järvinen, H1
Brinkman, K2
Atté, EF; Mugabo, J; Rasschaert, F; Reid, T; van Griensven, J; Zachariah, R1
Baiget, M; Cabeza, MC; Domingo, JC; Domingo, P; Fernandez, I; Gutierrez, Mdel M; Mateo, MG; Muñoz, J; Pruvost, A; Salazar, J; Vidal, F; Villarroya, F1
Bacchetti, P; Cofrancesco, J; Grunfeld, C; Heymsfield, S; Kronmal, R; Lewis, CE; Saag, M; Scherzer, R; Shlipak, M; Tien, PC1
Mugabo, J; Reid, T; van Griensven, J; Zachariah, R1
Chen, YM; Choi, JY; Han, SH; Law, MG; Lee, CK; Li, PC; Merati, TP; Oka, S; Phanuphak, N; Pujari, S; Saghayam, S; Saphonn, V; Sirisanthana, T; Sungkanuparph, S; Vanar, S; Zhang, F; Zhou, J1
Gu, WB; Han, Y; Li, TS; Li, YL; Qiu, ZF; Wu, P; Xie, J; Zhang, L1
Carrillo-Casas, E; Dantony, E; Ecochard, R; Etard, JF; Pinoges, L; Pujades-Rodríguez, M; Szumilin, E1
Baldi, A; Chirianni, A; De Luca, A; Esposito, V; Gargiulo, M; Lucariello, A; Manente, L; Parrella, G; Parrella, R; Perna, A; Viglietti, R1
Chokephaibulkit, K; Lapphra, K; Phongsamart, W; Prasitsuebsai, W; Sawawiboon, N; Wittawatmongkol, O1
Browne, SH; Conradie, MM; Cotton, MF; Edson, C; Haubrich, R; Hough, S; Innes, S; Jain, S; Rabie, H; Sun, X; van Niekerk, M; Zöllner, EW1
Abrams, EJ; Arpadi, S; Coovadia, A; Kuhn, L; Martens, L; Patel, F; Shiau, S; Strehlau, R1
Lauenroth-Mai, E; Schlote, F1
Aboulker, JP; Flandre, P; Harel, M; Joly, V; Leturque, N; Meiffredy, V; Yeni, P1
Carr, A; Cooper, DA; Hoy, J; Hudson, J; Law, M; Martin, A; Smith, DE1
Moyle, G1
Blanco, F; de la Cruz, JJ; García-Benayas, T; González-Lahoz, J; Soriano, V1
Oka, S; Teruya, K1
Baldwin, C; Gazzard, BG; Langroudi, B; Mandalia, S; Moyle, GJ1
Herrmann, SE; James, IR; John, M; Mallal, SA; McKinnon, EJ; Moore, CB; Nolan, DA; White, AJ1
Domingo, P; Ordoñez, J; Pérez, A; Rodriguez, J; Sambeat, MA; Vázquez, G1
Martínez, E1
Maa, JF; McComsey, G1
Bruunsgaard, H; Gerstoft, J; Keller, P; Lindegaard, B; Pedersen, BK1
Moyle, G; Sutinen, J1
Katzenstein, D1
Amin, J; Carr, A; Cooper, DA; Doong, N; Emery, S; Freund, J; Hoy, J; Martin, A; Ringland, C; Smith, DE; Workman, C1
Walker, UA1
Brinkman, K; Casula, M; de Ronde, A; Hulsebosch, HJ; Lange, J; Nieuwkerk, P; Reiss, P; van der Valk, M; van Eck-Smit, B; van Eeden, A; van Kuijk, K; Weverlingz, GJ1
Auclair, M; Capeau, J; Caron, M; Kornprobst, M; Lagathu, C; Lombès, A; Walker, UA1
Cherry, CL; Fisher, RL; Hernandez, JE; Hessenthaler, SM; Hoppel, CL; Lonergan, JT; McComsey, GA; Paulsen, DM; Ross, LL; Ross, ST; Thompson, KA; White-Owen, C; Williams, VC1
Bartsch, G; El-Sadr, WM; Gibert, C; Grunfeld, C; Kotler, D; Peng, G; Raghavan, S; Shlay, JC; Visnegarwala, F; Wang, J1
Cherry, CL; Hernandez, J; Lal, L; McComsey, G; McLean, CA; Ross, LL; Thompson, KA; Wesselingh, SL1
Balestre, E; Bernardin, E; Bonnet, F; Dabis, F; Neau, D; Pellegrin, JL1
Battegay, M; Bernasconi, E; Bucher, HC; Furrer, H; Hirschel, B; Rickenbach, M; Tarr, PE; Vernazza, P; Weber, R; Young, J1
Amellal, B; Buffet, M; Bui, P; Calvez, V; Deleuze, J; Dupin, N; Gorin, I; Gourlain, K; Morini, JP; Prévot, M; Schwarzinger, M1
García-Gibert, L; Giménez-Arnau, AM; Knobel, H; Montero, M1
Bowonwatanuwong, C; Desakorn, V; Krudsood, S; Pitisuttithum, P; Tin, EE; Wilairatana, P1
Bergersen, BM; Bruun, JN; Ellingsen, I; Sandvik, L1
Back, DJ; Gazzard, BG; Jones, SP; Lebrecht, D; Morelese, J; Moyle, GJ; Pirmohamed, M; Qazi, N; Sutinen, J; Walker, UA; Yki-Jărvinen, H1
Nolan, D1
Aquilina, C; Bagheri, H; Bernard, J; Bonnet, E; Delpierre, C; Labau, E; Marion-Latard, F; Massip, P; Montastruc, JL; Obadia, M; Sommet, A; Tavassoli, N1
Hall, DB; Lange, JM; Reiss, P; van Leth, F1
Cartledge, J; Churchill, D; Fakoya, A; Hay, P; Johnson, M; Leen, C; Moyle, GJ; Murphy, M; Reilly, G; Sabin, CA; Scullard, G; Wilkins, E1
Brown, TT; Cole, SR; DeHovitz, J; French, AL; Justman, JE; Nathwani, N; Schneider, MF; Tien, PC; Young, M1
Alonso, C; Aranda, M; Barrufet, P; Berenguer, J; Crespo, M; del Río, L; Delegido, A; Ferrer, E; Fisac, C; Gatell, JM; Lérida, A; Llibre, JM; Lonca, M; Martínez-Lacasa, J; Merino, E; Niubo, J; Pedreira, JD; Podzamczer, D; Pulido, F; Ribas, MA; Ribera, E; Rubio, R; Sanchez, P; Sanz, J; Veloso, S1
Amellal, B; Calvez, V; Castro, ND; Chêne, G; Cotte, L; Gourlain, K; Journot, V; Molina, JM; Palmer, P; Pédrono, G; Rancinan, C1
Arranz, JA; Asensi, V; del Arco, A; Estrada, V; Galindo, MJ; Lozano, F; Morales, D; Muñoz, A; Palacios, R; Rivero, A; Santos, J1
Casula, M; Nievaard, MA; Reiss, P; van der Valk, M; Wit, FW1
De Naeyer, L; Gashumba, D; Gazille, C; Mushi, T; Ubarijoro, S; van Griensven, J; Zachariah, R1
Behrens, GM; Das, AM; Lücke, T; Schmidt, RE; Stankov, MV1
Nelson, M; Waters, L1
Dubé, MP; Grinspoon, SK; Komarow, L; Mulligan, K; Parker, RA; Robbins, GK; Roubenoff, R; Tebas, P1
Borgonovo, S; Brambilla, P; Cafarelli, L; Giacomet, V; Mora, S; Viganò, A; Zamproni, I; Zuccotti, G1
Bernard, J; Bonnet, E; Fauvel, J; Massip, P; Perret, B; Ruidavets, JB1
Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Kouanfack, C; Koulla-Shiro, S; Laurent, C; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N1
Delaporte, E; Kouanfack, C; Laurent, C; Makinson, A; Moing, VL1

Reviews

7 review(s) available for stavudine and HIV-Associated Lipodystrophy Syndrome

ArticleYear
[Tenofovir as a strategy to avoid or limit adverse effects].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 8

    Topics: Adenine; Anemia; Anti-HIV Agents; Antimetabolites; Clinical Trials as Topic; DNA, Mitochondrial; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Glucose Metabolism Disorders; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Multicenter Studies as Topic; Organophosphonates; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Thymidine; Zidovudine

2008
Double "d" drug danger.
    The AIDS reader, 2003, Volume: 13, Issue:1

    Topics: Acidosis, Lactic; Anti-HIV Agents; Didanosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV-Associated Lipodystrophy Syndrome; Humans; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Stavudine

2003
[Antiretrovirals].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: Acidosis, Lactic; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Hemophilia A; Hemorrhage; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Indinavir; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2003
The reassurance of experience.
    International journal of STD & AIDS, 2003, Volume: 14 Suppl 1

    Topics: Anti-HIV Agents; DNA, Mitochondrial; Drug Resistance, Viral; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Stavudine

2003
Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?
    Drug safety, 2005, Volume: 28, Issue:12

    Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Cardiovascular Diseases; Cyclopropanes; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Metabolic Syndrome; Nevirapine; Oxazines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Zidovudine

2005
Long-term complications of antiretroviral therapy: lipoatrophy.
    International journal of clinical practice, 2007, Volume: 61, Issue:6

    Topics: Anti-HIV Agents; Body Image; Cardiovascular Diseases; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Stavudine; Time Factors; Zidovudine

2007
Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings.
    Expert opinion on drug safety, 2008, Volume: 7, Issue:3

    Topics: Acidosis, Lactic; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Health Resources; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Sex Factors; Stavudine

2008

Trials

17 trial(s) available for stavudine and HIV-Associated Lipodystrophy Syndrome

ArticleYear
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:5

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Intra-Abdominal Fat; Lopinavir; Male; Middle Aged; Nevirapine; Pyrimidinones; Radiography, Abdominal; Stavudine; Thigh; Viral Load; Zidovudine

2009
Improvements in cheek volume in lipoatrophic individuals switching away from thymidine nucleoside reverse transcriptase inhibitors.
    HIV medicine, 2009, Volume: 10, Issue:6

    Topics: Absorptiometry, Photon; Adenine; Adult; Aged; Body Composition; Cheek; Dideoxynucleosides; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Organophosphonates; Quality of Life; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Zidovudine

2009
Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.
    Archives of disease in childhood, 2013, Volume: 98, Issue:4

    Topics: Anti-HIV Agents; Body Composition; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Infant; Insulin Resistance; Lamivudine; Lipids; Lopinavir; Male; Nevirapine; Ritonavir; South Africa; Stavudine

2013
Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial.
    AIDS (London, England), 2002, Dec-06, Volume: 16, Issue:18

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Constitution; Body Mass Index; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Indinavir; Lamivudine; Male; Middle Aged; Risk Factors; Stavudine; Zidovudine

2002
Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.
    AIDS (London, England), 2002, Dec-06, Volume: 16, Issue:18

    Topics: Anti-HIV Agents; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Stavudine; Substance Withdrawal Syndrome; Thymidine; Zidovudine

2002
A 48-week, randomized, open-label comparison of three abacavir-based substitution approaches in the management of dyslipidemia and peripheral lipoatrophy.
    Journal of acquired immune deficiency syndromes (1999), 2003, May-01, Volume: 33, Issue:1

    Topics: Adult; Body Composition; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperlipidemias; Insulin Resistance; Male; Reverse Transcriptase Inhibitors; Stavudine; Time Factors

2003
Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients.
    Journal of acquired immune deficiency syndromes (1999), 2003, May-01, Volume: 33, Issue:1

    Topics: Adult; Body Composition; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Stavudine; Zidovudine

2003
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.
    AIDS (London, England), 2004, Apr-30, Volume: 18, Issue:7

    Topics: Absorptiometry, Photon; Adipose Tissue; Anti-HIV Agents; Body Composition; Bone Density; Dideoxynucleosides; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2004
Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.
    Antiviral therapy, 2004, Volume: 9, Issue:3

    Topics: Adipose Tissue; Adult; Anti-HIV Agents; DNA, Mitochondrial; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Leukocytes, Mononuclear; Middle Aged; Muscle, Skeletal; Radiography; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2004
Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine.
    Journal of acquired immune deficiency syndromes (1999), 2005, Feb-01, Volume: 38, Issue:2

    Topics: Adult; Anti-HIV Agents; Body Composition; Didanosine; Dideoxynucleosides; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin; Insulin Resistance; Lamivudine; Lipids; Male; Middle Aged; Prospective Studies; Stavudine

2005
The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.
    The Southeast Asian journal of tropical medicine and public health, 2005, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; CD4 Lymphocyte Count; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Stavudine

2005
A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy.
    AIDS (London, England), 2006, Oct-24, Volume: 20, Issue:16

    Topics: Adenine; Adult; Aged; Anti-HIV Agents; Biomarkers; Body Fat Distribution; Dideoxynucleosides; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lipids; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Zidovudine

2006
Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study.
    Journal of acquired immune deficiency syndromes (1999), 2007, Feb-01, Volume: 44, Issue:2

    Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Aged; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Extremities; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lipid Metabolism; Lipids; Male; Middle Aged; Oxazines; Stavudine; Viral Load

2007
Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
    AIDS research and human retroviruses, 2007, Volume: 23, Issue:1

    Topics: Adult; Anti-HIV Agents; Didanosine; DNA, Mitochondrial; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Leukocytes, Mononuclear; Logistic Models; Male; Reverse Transcriptase Inhibitors; Stavudine; Surveys and Questionnaires; Time Factors; Zidovudine

2007
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.
    Journal of acquired immune deficiency syndromes (1999), 2007, Aug-15, Volume: 45, Issue:5

    Topics: Absorptiometry, Photon; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Composition; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Prospective Studies; Stavudine; Time Factors; Treatment Outcome; United States; Zidovudine

2007
Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz.
    Antiviral therapy, 2007, Volume: 12, Issue:3

    Topics: Absorptiometry, Photon; Adenine; Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atrophy; Benzoxazines; Body Composition; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclopropanes; Female; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Italy; Male; Organophosphonates; Prospective Studies; Protease Inhibitors; Stavudine; Tenofovir; Time Factors; Treatment Outcome; Viral Load

2007
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
    AIDS research and human retroviruses, 2008, Volume: 24, Issue:3

    Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Patient Compliance; Peripheral Nervous System Diseases; Prospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine

2008

Other Studies

51 other study(ies) available for stavudine and HIV-Associated Lipodystrophy Syndrome

ArticleYear
REVERSIBILITY OF LIPOATROPHY IN HIV-INFECTED PATIENTS TAKING ANTIRETROVIRAL THERAPY: A COHORT STUDY WITH ULTRASOUND ASSESSMENT.
    Acta clinica Croatica, 2022, Volume: 61, Issue:1

    Topics: Cohort Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Longitudinal Studies; Prospective Studies; Stavudine; Zidovudine

2022
Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Ethiopian medical journal, 2012, Volume: 50, Issue:3

    Topics: Adult; Aged, 80 and over; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Ethiopia; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Interviews as Topic; Male; Metabolic Diseases; Middle Aged; Prevalence; Risk Factors; Stavudine; Surveys and Questionnaires; Zidovudine

2012
Small-dense LDL cholesterol/large-buoyant LDL cholesterol ratio as an excellent marker for indicating lipodystrophy in HIV-infected patients.
    American journal of clinical pathology, 2013, Volume: 140, Issue:4

    Topics: Adipose Tissue; Adult; Anti-HIV Agents; Biomarkers; Cholesterol, LDL; Cross-Sectional Studies; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Stavudine

2013
[Prevalence of metabolic complications after 10 years of antiretroviral treatment in Senegal].
    Bulletin de la Societe de pathologie exotique (1990), 2014, Volume: 107, Issue:4

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiovascular Diseases; Diabetes Mellitus; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lipodystrophy; Male; Metabolic Diseases; Middle Aged; Senegal; Stavudine

2014
Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.
    African health sciences, 2014, Volume: 14, Issue:2

    Topics: Adolescent; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; India; Male; Multivariate Analysis; Nevirapine; Prevalence; Risk Factors; Stavudine

2014
[To evaluate the changes in body composition in male human immunodeficiency virus-related lipodystrophy after different treatment regimens by dual-energy X-ray absorptiometry].
    Zhonghua nei ke za zhi, 2014, Volume: 53, Issue:8

    Topics: Absorptiometry, Photon; Adenine; Anti-HIV Agents; Antiviral Agents; Body Composition; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Organophosphonates; Stavudine; Tenofovir; Zidovudine

2014
Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection.
    European journal of gastroenterology & hepatology, 2015, Volume: 27, Issue:5

    Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Case-Control Studies; Coinfection; Didanosine; Female; Hepatitis C; Hispanic or Latino; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Liver Cirrhosis; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Time Factors

2015
Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009, Volume: 103, Issue:6

    Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Organophosphonates; Rwanda; Stavudine; Tenofovir; Treatment Outcome; Weight Loss; Zidovudine

2009
Assessment of ultrasound for use in detecting lipoatrophy in HIV-infected patients taking combination antiretroviral therapy.
    AIDS patient care and STDs, 2009, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Croatia; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Stavudine; Subcutaneous Fat; Ultrasonography; Young Adult

2009
Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
    HIV medicine, 2009, Volume: 10, Issue:5

    Topics: Adipose Tissue; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Image; Child; Cosmetic Techniques; Face; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Patient Satisfaction; Quality of Life; Self Concept; Stavudine; Transplantation, Autologous; Treatment Outcome; Young Adult

2009
Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenine; Adipose Tissue; Adult; Anti-HIV Agents; Body Fat Distribution; CD4 Lymphocyte Count; Deoxyguanosine; F2-Isoprostanes; Glutathione; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Mitochondria; Organophosphonates; Pyrimidinones; Ritonavir; Stavudine; Tenofovir; Treatment Outcome; Viral Load

2009
Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    The Journal of infectious diseases, 2009, Jul-15, Volume: 200, Issue:2

    Topics: Adipocytes; Anti-HIV Agents; DNA Polymerase gamma; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Female; Gene Expression Profiling; Gene Expression Regulation, Viral; Glucose; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Immunohistochemistry; Lipid Metabolism; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Stavudine; Subcutaneous Fat, Abdominal; Zidovudine

2009
Stavudine in antiretroviral therapy: is this the end?
    AIDS (London, England), 2009, Aug-24, Volume: 23, Issue:13

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine

2009
Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2010, Volume: 104, Issue:2

    Topics: Acidosis, Lactic; Adult; Age Factors; Anti-HIV Agents; Drug Therapy, Combination; Drugs, Generic; Exanthema; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Longitudinal Studies; Male; Nevirapine; Peripheral Nervous System Diseases; Proportional Hazards Models; Risk Factors; Rwanda; Stavudine; Time Factors

2010
Relationship between HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Apr-01, Volume: 50, Issue:7

    Topics: Adult; Anthropometry; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Intracellular Space; Leukocytes, Mononuclear; Male; Middle Aged; Polyphosphates; Stavudine

2010
Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy.
    AIDS (London, England), 2010, Jul-17, Volume: 24, Issue:11

    Topics: Adipose Tissue; Adult; Anti-HIV Agents; Body Composition; Body Fat Distribution; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Leg; Magnetic Resonance Imaging; Male; Middle Aged; Stavudine; Subcutaneous Fat

2010
Weight loss after the first year of stavudine-containing antiretroviral therapy and its association with lipoatrophy, virological failure, adherence and CD4 counts at primary health care level in Kigali, Rwanda.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2010, Volume: 104, Issue:12

    Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Medication Adherence; Rwanda; Stavudine; Viral Load; Weight Loss

2010
Recent FDA approvals and changes.
    AIDS patient care and STDs, 2011, Volume: 25, Issue:2

    Topics: Anti-HIV Agents; Child; Controlled Clinical Trials as Topic; Dideoxynucleosides; Drug Approval; Drug Labeling; Female; Growth Hormone-Releasing Hormone; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Infant; Infant, Newborn; Male; Nitriles; Pyridazines; Pyrimidines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine; United States; United States Food and Drug Administration

2011
Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD).
    Endocrine journal, 2011, Volume: 58, Issue:6

    Topics: Adult; Antiretroviral Therapy, Highly Active; Asia; Asian People; Cohort Studies; Databases, Factual; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Prevalence; Risk Factors; Stavudine; White People

2011
[Association between the change regularity of peripheral blood mononuclear cell mitochondrial deoxyribonucleic acid content and human immunodeficiency virus-related lipodystrophy].
    Zhonghua yi xue za zhi, 2011, Jun-07, Volume: 91, Issue:21

    Topics: Adult; Antiretroviral Therapy, Highly Active; Case-Control Studies; DNA, Mitochondrial; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Stavudine; Young Adult; Zidovudine

2011
Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dose-Response Relationship, Drug; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Stavudine; Time Factors

2011
Role of FAP48 in HIV-associated lipodystrophy.
    Journal of cellular biochemistry, 2012, Volume: 113, Issue:11

    Topics: Adaptor Proteins, Signal Transducing; Adipocytes; Alkynes; Animals; Antiretroviral Therapy, Highly Active; Benzoxazines; Calcineurin; Carbamates; Cell Differentiation; Cell Line; Cyclopropanes; Furans; Gene Expression; Glucocorticoids; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Indinavir; Mice; Saquinavir; Signal Transduction; Stavudine; Sulfonamides; Transfection

2012
Lipodystrophy and reversal of facial lipoatrophy in perinatally HIV-infected children and adolescents after discontinuation of stavudine.
    International journal of STD & AIDS, 2012, Volume: 23, Issue:7

    Topics: Adolescent; Analysis of Variance; Child; Cohort Studies; Face; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Infectious Disease Transmission, Vertical; Male; Stavudine

2012
High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.
    BMC pediatrics, 2012, Nov-23, Volume: 12

    Topics: Absorptiometry, Photon; Adiposity; Anti-HIV Agents; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Linear Models; Logistic Models; Male; Prevalence; Risk Factors; South Africa; Stavudine; Time Factors

2012
HIV-associated lipodystrophy syndrome: LioN-HAART cohort: (lipodystrophy in patients on nucleoside-based HAART). Highly active antiretroviral therapy.
    Journal of acquired immune deficiency syndromes (1999), 2002, Oct-01, Volume: 31, Issue:2

    Topics: Adult; Age Factors; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cohort Studies; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Prospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Time Factors; Zidovudine

2002
Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy.
    AIDS (London, England), 2003, Apr-11, Volume: 17, Issue:6

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Dideoxynucleosides; Female; Follow-Up Studies; HIV Reverse Transcriptase; HIV-Associated Lipodystrophy Syndrome; Humans; Lactic Acid; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine

2003
Fat distribution and metabolic abnormalities in HIV-infected patients on first combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor.
    Antiviral therapy, 2003, Volume: 8, Issue:3

    Topics: Adult; Anthropometry; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Exercise; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2003
Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy.
    The AIDS reader, 2003, Volume: 13, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Integration Host Factors; Leptin; Male; Middle Aged; Retrospective Studies; Stavudine; Zidovudine

2003
Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients.
    Clinical and experimental immunology, 2004, Volume: 135, Issue:2

    Topics: Adiponectin; Adipose Tissue; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Interleukin-6; Male; Middle Aged; Protease Inhibitors; Proteins; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Tumor Necrosis Factor-alpha

2004
Managing HIV lipoatrophy.
    Lancet (London, England), 2004, Feb-07, Volume: 363, Issue:9407

    Topics: Anti-HIV Agents; Dideoxynucleosides; HIV-Associated Lipodystrophy Syndrome; Human Growth Hormone; Humans; Hypoglycemic Agents; Metabolic Syndrome; Protease Inhibitors; Randomized Controlled Trials as Topic; Recombinant Proteins; Reverse Transcriptase Inhibitors; Rosiglitazone; Stavudine; Thiazolidinediones; Treatment Outcome

2004
[Long-term tolerance. Preventing lipoatrophy].
    MMW Fortschritte der Medizin, 2003, Apr-28, Volume: 145 Spec No 1

    Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Dideoxynucleosides; DNA, Mitochondrial; Drug Combinations; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Long-Term Care; Risk Factors; Stavudine; Zidovudine

2003
The longer the better? Four years of durable, initially boosted protease treatment.
    AIDS (London, England), 2004, Mar-26, Volume: 18, Issue:5

    Topics: Antiretroviral Therapy, Highly Active; Gastrointestinal Diseases; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lopinavir; Pyrimidinones; Ritonavir; Stavudine; Time Factors; Treatment Failure

2004
Acquired and inherited lipodystrophies.
    The New England journal of medicine, 2004, Jul-01, Volume: 351, Issue:1

    Topics: DNA, Mitochondrial; HIV-Associated Lipodystrophy Syndrome; Humans; Mitochondria; Mutation; Reverse Transcriptase Inhibitors; Stavudine

2004
The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro.
    AIDS (London, England), 2004, Nov-05, Volume: 18, Issue:16

    Topics: 3T3-L1 Cells; Adenine; Adipocytes; Animals; Apoptosis; Cell Differentiation; Didanosine; Dideoxynucleosides; HIV-1; HIV-Associated Lipodystrophy Syndrome; Lamivudine; Lipid Metabolism; Mice; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Zidovudine

2004
Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine.
    AIDS (London, England), 2005, Jan-03, Volume: 19, Issue:1

    Topics: Adipocytes; Adipose Tissue; Adult; Apoptosis; Dideoxynucleosides; DNA, Mitochondrial; Electron Transport; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Mitochondria; Muscle, Skeletal; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2005
Lipoatrophy and mitochondrial DNA assays: see all, know all?
    AIDS (London, England), 2005, Jan-03, Volume: 19, Issue:1

    Topics: Apoptosis; Dideoxynucleosides; DNA, Mitochondrial; Electron Transport; HIV-Associated Lipodystrophy Syndrome; Humans; Reverse Transcriptase Inhibitors; Stavudine

2005
Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine.
    Journal of acquired immune deficiency syndromes (1999), 2005, Mar-01, Volume: 38, Issue:3

    Topics: Adipocytes; Adipose Tissue; Adult; Anti-HIV Agents; Apoptosis; Biopsy; Dideoxynucleosides; DNA; DNA Fragmentation; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; In Situ Nick-End Labeling; Male; Middle Aged; Stavudine; Zidovudine

2005
Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999--2003.
    Antiviral chemistry & chemotherapy, 2005, Volume: 16, Issue:1

    Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; Age Factors; Anti-HIV Agents; CD4 Antigens; Cohort Studies; Didanosine; Drug Therapy, Combination; HIV-Associated Lipodystrophy Syndrome; Humans; Lactic Acid; Longitudinal Studies; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Triglycerides

2005
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
    Antiviral therapy, 2005, Volume: 10, Issue:1

    Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Switzerland

2005
Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2005, Volume: 33, Issue:1

    Topics: Adipose Tissue; Adolescent; Adult; Aged; Anti-HIV Agents; Didanosine; DNA, Mitochondrial; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine

2005
[Toxic epidermal necrolysis associated with abacavir].
    Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:4

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Dideoxynucleosides; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Stevens-Johnson Syndrome

2005
Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive.
    HIV medicine, 2005, Volume: 6, Issue:4

    Topics: Adipose Tissue; Anti-HIV Agents; Blood Pressure; Body Composition; CD4 Lymphocyte Count; Cholesterol; Cholesterol, HDL; Cohort Studies; Diet; Exercise; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertension; Hypolipidemic Agents; Male; Risk Factors; Sex Factors; Stavudine; Time Factors; Triglycerides; Weight Loss

2005
Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.
    Journal of acquired immune deficiency syndromes (1999), 2005, Dec-15, Volume: 40, Issue:5

    Topics: Adiponectin; Adipose Tissue; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Mitochondrial; Drug Therapy, Combination; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Interleukin-6; Male; Middle Aged; Mitochondria; Reverse Transcriptase Inhibitors; Stavudine; Sterol Regulatory Element Binding Protein 1; Tumor Necrosis Factor-alpha; Zidovudine

2005
Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
    Pharmacotherapy, 2006, Volume: 26, Issue:2

    Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Anti-HIV Agents; Body Composition; Cross-Sectional Studies; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Stavudine

2006
Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudine.
    HIV medicine, 2006, Volume: 7, Issue:6

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cholesterol; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lipids; Lipoproteins; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Stavudine; Triglycerides

2006
Relation of stavudine discontinuation to anthropometric changes among HIV-infected women.
    Journal of acquired immune deficiency syndromes (1999), 2007, Jan-01, Volume: 44, Issue:1

    Topics: Adult; Anthropometry; Anti-HIV Agents; Cohort Studies; Female; Hip; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Stavudine

2007
Cervical lipomatosis in HIV-infected patients: a case-control study.
    HIV medicine, 2007, Volume: 8, Issue:1

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cohort Studies; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lipomatosis; Logistic Models; Male; Middle Aged; Prevalence; Risk Factors; Spain; Spinal Diseases; Stavudine

2007
Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition.
    HIV medicine, 2007, Volume: 8, Issue:1

    Topics: Adipocytes; Adipose Tissue; Adult; Dideoxynucleosides; DNA, Mitochondrial; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lumbosacral Region; Male; Middle Aged; Netherlands; Reverse Transcriptase Inhibitors; Stavudine; Thigh

2007
High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2007, Volume: 101, Issue:8

    Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lipodystrophy; Male; Prevalence; Rwanda; Sex Factors; Stavudine

2007
Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors.
    Antiviral therapy, 2007, Volume: 12, Issue:2

    Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Cell Differentiation; Cell Proliferation; Cell Shape; Dideoxynucleosides; DNA, Mitochondrial; Dose-Response Relationship, Drug; Electron Transport; HIV-Associated Lipodystrophy Syndrome; Mice; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Triglycerides; Zalcitabine; Zidovudine

2007
Association of APOC3 polymorphisms with both dyslipidemia and lipoatrophy in HAART-receiving patients.
    AIDS research and human retroviruses, 2008, Volume: 24, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apolipoprotein C-III; Body Composition; Body Fat Distribution; Cross-Sectional Studies; Dyslipidemias; France; Gene Frequency; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lipoproteins; Male; Middle Aged; Polymorphism, Genetic; Stavudine; Triglycerides

2008